Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
5.51
+0.12 (2.23%)
At close: Sep 18, 2024, 4:00 PM
5.62
+0.11 (2.00%)
After-hours: Sep 18, 2024, 4:58 PM EDT

Verve Therapeutics Market Cap

Verve Therapeutics has a market cap or net worth of $466.28 million as of September 18, 2024. Its market cap has decreased by -45.60% in one year.

Market Cap
466.28M
Enterprise Value
-37.19M
1-Year Change
-45.60%
Ranking
Category
Stock Price
$5.51

Market Cap Chart

Since the IPO on June 17, 2021, Verve Therapeutics's market cap has decreased from $869.34M to $466.28M, a decrease of -46.36%. That is a compound annual growth rate of -17.42%.

History

DateMarket Cap% Change
Sep 17, 2024456.10M-48.68%
Dec 29, 2023888.70M-25.44%
Dec 30, 20221.19B-32.89%
Dec 31, 20211.78B104.31%
View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Valneva SE 499.62M
Tourmaline Bio 494.75M
Contineum Therapeutics 493.50M
Aura Biosciences 491.10M
Cross Country Healthcare 489.21M
EyePoint Pharmaceuticals 483.80M
ZimVie 478.10M
KalVista Pharmaceuticals 477.96M
Market Cap Rankings